D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data

Mataix-Cols, David, Fernández de la Cruz, Lorena, Monzani, Benedetta, Rosenfield, David, Andersson, Erik, Pérez-Vigil, Ana, Frumento, Paolo, de Kleine, Rianne A. +49 more·2017·JAMA Psychiatry
DOI 10.1001/jamapsychiatry.2016.3955

Cited by (287)

Items 101–200 of 287

  1. Estradiol-induced enhancement of fear extinction in female rats: The role of NMDA receptor activation
    Bronwyn M. Graham, Elliot Scott · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  2. Developments of prolonged exposure in treatment effect of post‐traumatic stress disorder and controlling dropout rate: A meta‐analytic review
    Yaoguang Zhou, Luna Sun, Yan Wang, Lili Wu, Zhuoer Sun, Fan Zhang, Weizhi Liu · 2020 · Clinical Psychology & Psychotherapy
  3. Astrocytic NMDA Receptors in the Basolateral Amygdala Contribute to Facilitation of Fear Extinction
    Gajanan P. Shelkar, Jinxu Liu, Shashank Manohar Dravid · 2021 · The International Journal of Neuropsychopharmacology
  4. A Case for Translation From the Clinic to the Laboratory
    Maria Alexandra Kredlow, Lycia D. de Voogd, Elizabeth A. Phelps · 2022 · Perspectives on Psychological Science
  5. Aerobic exercise after extinction learning reduces return of fear and enhances memory of items encoded during extinction learning
    Kevin M. Crombie, Ameera Azar, Chloe Botsford, Mickela O. Heilicher, Nicole Moughrabi, Tijana Sagorac Gruichich, Chloe M. Schomaker, Joseph E. Dunsmoor, Josh M. Cisler · 2023 · Mental health and physical activity
  6. Hydrogen sulfide: a target to modulate oxidative stress and neuroplasticity for the treatment of pathological anxiety
    Mary Chen, Caroline E. Pritchard, Diandra Fortune, Priyadurga Kodi, Marco A. Grados · 2019 · Expert Review of Neurotherapeutics
  7. Neurocognitive processes in d-cycloserine augmented single-session exposure therapy for anxiety: A randomized placebo-controlled trial
    Andrea Reinecke, Alecia Nickless, Michael D Browning, Catherine J. Harmer · 2020 · Behaviour Research and Therapy
  8. Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges
    Michael J. Lucido, Boadie Waid Dunlop · 2025 · Brain Sciences
  9. Recent Developments in Psychopharmaceutical Approaches to Treating Female Sexual Interest and Arousal Disorder
    Stephanie Both · 2017 · Current Sexual Health Reports
  10. Pharmacotherapy for Anxiety Disorders.
    O’Leary, Kerry B., Khan, Jeffrey S. · 2024 · Psychiatric Clinics of North America
  11. Ventromedial and insular cortical volume moderates the relationship between BDNF Val66Met and threat sensitivity
    Dmitri A. Young, Linda L. Chao, Huaiyu Zhang, Thomas J. Metzler, Jessica A. Ross, Anne L. Richards, Aoife O’Donovan, Sabra S. Inslicht, Thomas C. Neylan · 2021 · Journal of Psychiatric Research
  12. Enhanced exposure therapy for combat-related Posttraumatic Stress Disorder (PTSD): Study protocol for a randomized controlled trial
    JoAnn Difede, Barbara O. Rothbaum, Albert Rizzo, Katarzyna Wyka, Lisa A. Spielman, Tanja Jovanović, Christopher Reist, Michael J. Roy, Seth Davin Norrholm, Charles E. Glatt et al. · 2019 · Contemporary Clinical Trials
  13. Dissociated Role of D-Serine in Extinction During Consolidation vs. Reconsolidation of Context Conditioned Fear
    Ran Inoue, Gourango Talukdar, Keizo Takao, Tsuyoshi Miyakawa, Hisashi Mori · 2018 · Frontiers in Molecular Neuroscience
  14. Augmentation of Psychotherapy with Neurobiological Methods: Current State and Future Directions
    Elisabeth Hertenstein, Ersilia Trinca, Carlotta Louisa Schneider, Marina Wunderlin, Kristoffer Daniel Fehér, Dieter Wilhelm Riemann, Christoph Nissen · 2021 · Neuropsychobiology
  15. Treatment Approaches for Posttraumatic Stress Disorder Derived From Basic Research on Fear Extinction
    Jessica L. Maples‐Keller, Laura E. Watkins, Natalie M. Hellman, Nathaniel Luke Phillips, BARBARA OLASOV ROTHBAUM · 2024 · Biological Psychiatry
  16. Parsing neural circuits of fear learning and extinction across basic and clinical neuroscience: Towards better translation
    Ho Namkung, Kerrie L. Thomas, Jérémy Hall, Akira Sawa · 2021 · Neuroscience & Biobehavioral Reviews
  17. Prolonged Exposure Therapy
    Carmen P. McLean, Edna B. Foa · 2022 · Springer eBooks
  18. Obsessive compulsive disorder (OCD): Current treatments and a framework for neurotherapeutic research
    Erik Z. Woody, Kurt Leroy Hoffman, Henry Szechtman · 2019 · Advances in pharmacology
  19. Sudden gains in internet-based cognitive behavior therapy for obsessive-compulsive disorder
    Adel Abu Hamdeh, Johan Bjureberg, Fabian Lenhard, Erik Hedman‐Lagerlöf, Oskar Flygare, Lina Lundström, Brjánn Ljótsson, David Mataix‐Cols, Christian Rück, Erik Andersson · 2018 · Journal of Obsessive-Compulsive and Related Disorders
  20. Is glutamate associated with fear extinction and cognitive behavior therapy outcome in OCD? A pilot study
    Mònica Giménez, Marta Cano, Ignacio Martínez‐Zalacaín, Eva Real, Pino Alonso, Cinto Segalàs, Josep Munuera, Lawrence S. Kegeles, Jodi J. Weinstein, X. Xu et al. · 2019 · European Archives of Psychiatry and Clinical Neuroscience
  21. Effect of the NMDA receptor partial agonist, d-cycloserine, on emotional processing and autobiographical memory
    Runsen Chen, Liliana P. Capitão, Philip J. Cowen, Catherine J. Harmer · 2020 · Psychological Medicine
  22. Prevention of the return of extinguished fear by disrupting the interaction of neuronal nitric oxide synthase with its carboxy-terminal PDZ ligand
    Cheng‐Feng Qin, Xin-Lan Bian, Hai‐Yin Wu, Jia-Yun Xian, Yu‐Hui Lin, Cheng-Yun Cai, Ying Zhou, Xiao‐Lin Kou, Tingyou Li, Lei Chang et al. · 2021 · Molecular Psychiatry
  23. D-Cycloserine augmentation of cognitive behavior therapy for pediatric OCD: Predictors and moderators of outcome
    Sabine Wilhelm, Noah C. Berman, Brent J. Small, Rachel Porth, Eric A. Storch, DANIEL A. GELLER · 2018 · Journal of Affective Disorders
  24. Learn to forget: Does post-exposure administration of d-cycloserine enhance fear extinction in agoraphobia?
    Lena Pyrkosch, Jennifer Mumm, Isabel Alt, Lydia Fehm, Thomas Fydrich, Jens Plag, Andreas Ströhle · 2018 · Journal of Psychiatric Research
  25. A Theory of Everything: Overlapping Neurobiological Mechanisms of Psychotherapies of Fear and Anxiety Related Disorders
    Arash Javanbakht · 2019 · Frontiers in Behavioral Neuroscience
  26. Pharmacotherapy of anxiety disorders in the 21st century: A call for novel approaches
    Éric Bui, Franklin King, Andrew Melaragno · 2019 · General Psychiatry
  27. Causally mapping human threat extinction relevant circuits with depolarizing brain stimulation methods
    Ryan D. Webler, Desmond J. Oathes, Sanne J.H. van Rooij, Jonathan C. Gewirtz, Ziad H. Nahas, Shmuel M. Lissek, Alik S. Widge · 2022 · Neuroscience & Biobehavioral Reviews
  28. A transdiagnostic meta-analysis of acute augmentations to psychological therapy
    Camilla L. Nord, Beth F. Longley, Quentin Dercon, Veronica Phillips, Julia Funk, Siobhan Gormley, Rachel Knight, Alicia Smith, Tim Dalgleish · 2023 · Nature Mental Health
  29. Stimulation of N-methyl-D-aspartate receptors by exogenous and endogenous ligands improves outcome of brain injury
    Anat R Biegon, Sigal Liraz Zaltsman, Esther Shohami · 2018 · Current Opinion in Neurology
  30. Management of Treatment-Resistant Posttraumatic Stress Disorder
    Jonathan Starke, Dan Joseph Stein · 2017 · Current Treatment Options in Psychiatry
  31. d-Cycloserine and estradiol enhance fear extinction in nulliparous but not primiparous female rats
    Samantha Tang, Bronwyn M. Graham · 2019 · Neurobiology of Learning and Memory
  32. MDMA-Assisted Therapy as a Means to Alter Affective, Cognitive, Behavioral, and Neurological Systems Underlying Social Dysfunction in Social Anxiety Disorder
    Luoma, Jason, Lear, M. Kati · 2021 · Frontiers in Psychiatry
  33. Psychotherapie der Angststörungen: State of the Art
    Jürgen Hoyer, Ulrike Lueken · 2021 · Der Nervenarzt
  34. Adjunctive cognitive training with exposure enhances fear and neural outcomes in social anxiety
    Morgan M. Caudle, N. Dugas, Daniel M. Stout, Tali Manber Ball, Jessica A. Bomyea · 2023 · Psychiatry Research
  35. Current status of biological treatment options in Autism Spectrum Disorder
    Valsamma Eapen, Laura E. Nicholls, Vanessa Spagnol, Nisha Elizabeth Mathew · 2017 · Asian Journal of Psychiatry
  36. N-methyl-d-aspartate Partial Agonist Enhanced Intensive Cognitive-Behavioral Therapy of Panic Disorder in Adolescents
    Ovsanna T. Leyfer, Aubrey L. Carpenter, Donna B. Pincus · 2018 · Child Psychiatry & Human Development
  37. Ketamine-enhanced prolonged exposure therapy in veterans with PTSD: A randomized controlled trial protocol
    Paulo R. Shiroma, PAUL D. THURAS, Melissa Anderson Polusny, Shannon Kehle‐Forbes, Seth G. Disner, José V. Pardo, Casey S. Gilmore, Brian Tolly, Emily K. Voller, Eliza S. McManus et al. · 2024 · Contemporary Clinical Trials
  38. Augmenting Treatment for Posttraumatic Stress Disorder and Co-Occurring Conditions with Oxytocin
    Julianne C. Flanagan, Jennifer Mitchell · 2019 · Current Treatment Options in Psychiatry
  39. Timing is everything: Developmental differences in the effect of chronic corticosterone exposure on extinction retention.
    Anthea A. Stylianakis, Rick Richardson, Kathryn Baker · 2019 · Behavioral Neuroscience
  40. Theranostic pharmacology in PTSD: Neurobiology and timing
    Ralph J. Koek, Tinh N. Luong · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  41. Gut microbiota in anxiety and depression: Pathogenesis and therapeutics
    Stefano Bibbò, Salvatore Fusco, Gianluca Ianiro, Carlo Romano Settanni, Daniele Ferrarese, Claudio Grassi, Giovanni Cammarota, Antonio Gasbarrini · 2022 · Frontiers in Gastroenterology
  42. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) 2025 international guidelines for the management of patients with obsessive-compulsive disorder
    Michael Van Ameringen, Naomi Anne Fineberg, Arun V Ravindran, Paul Daniel Arnold, Serge Beaulieu, Vlasios Brakoulias, Elisa Macedo Brietzke, Yekta Dowlati, Lynne M. Drummond, Casara Jean Ferretti et al. · 2026 · Journal of Psychiatric Research
  43. Selective δ-Opioid Receptor Agonist, KNT-127, Facilitates Contextual Fear Extinction via Infralimbic Cortex and Amygdala in Mice
    Ayako Kawaminami, Daisuke Yamada, Shoko Yanagisawa, Motoki Shirakata, Keita Iio, Hiroshi Nagase, Akiyoshi Saitoh · 2022 · Frontiers in Behavioral Neuroscience
  44. Deficits in opioid receptor-mediated prediction error contribute to impaired fear extinction during adolescence
    Madelyne A. Bisby, Kathryn Baker, Rick Richardson · 2020 · Behaviour Research and Therapy
  45. Investigating d-cycloserine as a potential pharmacological enhancer of an emotional bias learning procedure
    Marcella Lydia Woud, Simon Edward Blackwell, Susann Steudte‐Schmiedgen, Michael D Browning, Emily Alexandra Holmes, Catherine J. Harmer, Jürgen Margraf, Andrea Reinecke · 2018 · Journal of Psychopharmacology
  46. Enhancing Fear Extinction: Pharmacological Approaches
    Olga Y. Ponomareva, Robert J. Fenster, Kerry James Ressler · 2023 · Current topics in behavioral neurosciences
  47. Pediatric Treatment-Resistant Obsessive Compulsive Disorder: Treatment Options and Challenges
    Sana Younus, Lauren K. Havel, Jordan T. Stiede, Catherine E. Rast, Kirti Saxena, Wayne K. Goodman, Eric A. Storch · 2024 · Pediatric Drugs
  48. GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy
    Johannes R. Lemke, Andrea Eoli, Ilona Krey, Bernt Popp, Vincent Strehlow, Dirk Alexander Wittekind, Anna‐Leena Vuorinen, Hesham Aldhalaan, Sarah Baer, Anne de Saint Martin et al. · 2025 · Molecular Psychiatry
  49. Effects of sodium benzoate on cognitive function in neuropsychiatric disorders: a systematic review and meta-analysis
    Chun-Wei Liang, Hsiao-Yi Cheng, Mei‐Chih Meg Tseng · 2024 · Frontiers in Psychiatry
  50. d-Cycloserine-Augmented Behavior Therapy for Body Dysmorphic Disorder: A Preliminary Efficacy Trial
    Hilary M. Weingarden, Suraj Sarvode Mothi, Ilana Ladis, Susanne S. Hoeppner, Hannah E. Reese, Kiara R. Timpano, Jedidiah Siev, Jessica L. Rasmussen, Jennifer D. Ragan, Darin Dean Dougherty et al. · 2019 · Cognitive Therapy and Research
  51. Exploring genetic variants in obsessive compulsive disorder severity: A GWAS approach
    María Alemany-Navarro, Raquel Cruz, Eva Real, Cinto Segalàs, Sara Bertolín, Isabel Baenas, Laura Domènech, Raquel Rabionet, Ángel Carracedo, José Manuel Menchón et al. · 2020 · Journal of Affective Disorders
  52. Bright light exposure augments cognitive behavioral therapy for panic and posttraumatic stress disorders: a pilot randomized control trial
    Aoi Kawamura, Takuya Yoshiike, Atsushi Yoshimura, Hazuki Koizumi, Kentaro Nagao, Yusuke Fujii, Masanori Takami, Masahiro Takahashi, Masahiro Matsuo, Naoto Yamada et al. · 2019 · Sleep and Biological Rhythms
  53. Therapieresistenz bei Angsterkrankungen – Definition und Behandlungsoptionen
    Katharina Domschke, Andreas Ströhle, Peter Zwanzger · 2024 · Der Nervenarzt
  54. Cognitive-Behavioral Therapy Enhancement Strategies
    David F. Tolin, Kayla A. Lord, Kelly A. Knowles · 2024 · Psychiatric Clinics of North America
  55. Psychophysiology of emotional responding in PTSD
    Brittney P. Innocente, Leah T. Weingast, Renie George, Seth Davin Norrholm · 2020 · Elsevier eBooks
  56. Specific Phobia
    Oar, Ella L., Farrell, Lara J., Ollendick, Thomas H. · 2019 · Pediatric Anxiety Disorders
  57. A precision medicine approach to pharmacological adjuncts to extinction: A call to broaden research
    King, Gabrielle, Baker, Kathryn D., Bisby, Madelyne A., Chan, Diana, Cowan, Caitlin S. M., Stylianakis, Anthea A., Zimmermann, Kelsey S., Richardson, Rick · 2019 · Psychopharmacology
  58. Preclinical behavioral and pharmacological treatments for enhancing fear extinction in adolescence
    Emily K. Wall, Elizabeth A Virakorn, Kathryn Baker, E Myfanwy Cohen, Rick Richardson · 2025 · Neuroscience & Biobehavioral Reviews
  59. New Agents in the Treatment of Psychiatric Disorders: What Innovations and in What Areas of Psychopathology?
    Paola Bozzatello, Roberta Novelli, Rebecca Schisano, Claudio Brasso, Paola Rocca, Silvio Bellino · 2025 · Pharmaceuticals
  60. Grant Report on D-Serine Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia †
    Natalie de la Garrigue, Juliana Glasser, Pejman Sehatpour, Dan Vlad Iosifescu, Elisa C. Dias, Marlene Carlson, Constance B. Shope, Tarek M. Sobeih, Tse Hwei Choo, Melanie M. Wall et al. · 2020 · Journal of Psychiatry and Brain Science
  61. Treatment of disgust in specific emotional disorders
    Catherine E. Rast, Sarah E. Woronko, Sarah C. Jessup, Bunmi O. Olatunji · 2023 · Bulletin of the Menninger Clinic
  62. Treatment of Anxiety in Children and Adolescents
    Tiah L. Dowell, Caroline L. Donovan, Lara J. Farrell, Allison M. Waters · 2018 · Current Treatment Options in Psychiatry
  63. A Review of PTSD Augmentation Strategies for Older Adults and Case of rTMS-Augmented Prolonged Exposure
    Carly W. Yasinski, Jessica L. Maples‐Keller, Hannah Trautner, Gregory P. Job, Sheila A. M. Rauch, William Maffitt McDonald, BARBARA OLASOV ROTHBAUM · 2020 · American Journal of Geriatric Psychiatry
  64. Enhancing panic and smoking reduction treatment with D-Cycloserine: a pilot randomized clinical trial
    Smits, Jasper A.J., Zvolensky, Michael J., Otto, Michael W., Piper, Megan E., Baird, Scarlett O., Kauffman, Brooke Y., Lee-Furman, Eunjung, Alavi, Noura, Dutcher, Christina D., Papini, Santiago et al. · 2020 · Drug and Alcohol Dependence
  65. Cognitive processing biases of social anxiety in adults who do and do not stutter
    Michelle Carr Swift, Martha Depasquale, Junwen Chen · 2024 · Journal of Communication Disorders
  66. Pharmacological enhancement of fear extinction
    B Davis, Benjamin M. Rosenberg, Matthew Gene Kearney, Michael Treanor, Michelle Genevieve Craske, Tom Joseph Barry · 2025 · Trends in Cognitive Sciences
  67. Chapter 15. Trauma- and Stressor-Related Disorders
    Frederick J. Stoddard, Naomi M. Simon, Roger K. Pitman · 2019 · American Psychiatric Association Publishing eBooks
  68. The effect of d-cycloserine on brain processing of breathlessness over pulmonary rehabilitation: an experimental medicine study
    Sarah Finnegan, Olivia K. Harrison, Sara Booth, Andrea Dennis, Martyn Ezra, Catherine J. Harmer, Mari Herigstad, Bryan Guillaume, Thomas E. Nichols, Najib Mahboob Rahman et al. · 2023 · ERJ Open Research
  69. Effects of D-cycloserine augmentation on cognitive behavioral therapy in patients with obsessive-compulsive disorder: A systematic review and meta-analysis
    Wenjie Gu, Eric A. Storch, Qing Zhao, Tingting Xu, Zhen Wang · 2017 · Journal of Obsessive-Compulsive and Related Disorders
  70. D-cycloserine as adjunct to brief computerised CBT for spider fear: Effects on fear, behaviour, and cognitive biases
    Nils Kappelmann, Mareike Suesse, Susann Steudte‐Schmiedgen, Reinoud Kaldewaij, Michael D Browning, Tanja Michael, Mike Rinck, Andrea Reinecke · 2019 · Journal of Behavior Therapy and Experimental Psychiatry
  71. Testing the efficacy of a brief exercise intervention for enhancing exposure therapy outcomes
    Jaclyn S. Weisman, Thomas L. Rodebaugh · 2020 · Journal of Anxiety Disorders
  72. Cathodal transcranial direct current stimulation on the prefrontal cortex applied after reactivation attenuates fear memories and prevent reinstatement after extinction
    Johanna Marcela Duran, Rodrigo O. Sierra, Karen Corredor, Fernando P. Cárdenas · 2021 · Journal of Psychiatric Research
  73. Specialty knowledge and competency standards for pharmacotherapy for pediatric obsessive-compulsive disorder
    Bernhard Weidle, Tord Ivarsson, Fernando Ramos Asbahr, Rosa M Calvo, David Mataix‐Cols, Moira A. Rynn, Eric A. Storch · 2021 · Psychiatry Research
  74. A systematic review of the pharmacological modulation of autobiographical memory specificity
    Emma Cawley, Giulia G. Piazza, Ravi Das, Sunjeev K. Kamboj · 2022 · Frontiers in Psychology
  75. Empirically Supported Treatment Options for Children and Adolescents with Posttraumatic Stress Disorder: Integrating Network Models and Treatment Components
    Carl F. Weems, Erin L. Neill · 2020 · Current Treatment Options in Psychiatry
  76. Does d-cycloserine facilitate the effects of homework compliance on social anxiety symptom reduction?
    Andres D. Roque, David Rosenfield, Jasper A. J. Smits, Naomi M. Simon, Michael W. Otto, Luana M. Marques, Mark H. Pollack, Stefan G. Hofmann, Alicia E. Meuret · 2017 · Journal of Anxiety Disorders
  77. Rethinking psychotherapy
    Dan Joseph Stein, Judith Bass, Stefan G. Hofmann, Mark van Ommeren · 2019 · Elsevier eBooks
  78. Brain Imaging in Psychiatry: Time to Move From Regions of Interest and Interpretive Analyses to Connectomes and Predictive Modeling?
    Chadi G. Abdallah, Sameer Anil Sheth, Eric A. Storch, Wayne K. Goodman · 2023 · American Journal of Psychiatry
  79. Overcoming barriers in cognitive-behavioral therapy for youth anxiety and obsessive-compulsive disorder: Addressing parent behaviors
    Erika A. Chiappini, Carisa Parrish, Elizabeth K. Reynolds, Joseph F. Mcguire · 2021 · Bulletin of the Menninger Clinic
  80. Genetische Grundlagen der Posttraumatischen Belastungsstörung (PTBS)
    Elisabeth M. Weiss, Walther Parson, Harald Niederstätter, Josef Marksteiner, Astrid Lampe · 2018 · PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie
  81. Using pre-treatment de novo threat conditioning outcomes to predict treatment response to DCS augmentation of exposure-based CBT
    Rebecca E. Lubin, Hayley E. Fitzgerald, David Rosenfield, Joseph K. Carpenter, Santiago Papini, Christina D. Dutcher, Sheila M. Dowd, Stefan G. Hofmann, Mark H. Pollack, Jasper A. J. Smits et al. · 2023 · Journal of Psychiatric Research
  82. Treatment-Resistant Panic Disorder
    Mu‐Hong Chen, Shih‐Jen Tsai · 2018 · Springer eBooks
  83. Empirical status of mechanisms of change.
    Janna Nonja Vrijsen, Rianne A. de Kleine, Eni Sabine Becker, Amy E. Wenzel, Jasper A. J. Smits · 2021 · American Psychological Association eBooks
  84. Exposure Therapy Consortium: Outcomes of the Proof-of-Principle Study
    Jasper A. J. Smits, Jonathan S. Abramowitz, Rebecca Anderson, Joanna J. Arch, Daniel Badeja, Snir Barzilay, Amanda Belanger, Thomas Borchert, Emma Bryant, Alane S. Burger et al. · 2024 · Journal of Anxiety Disorders
  85. New and emerging treatments for anxiety disorders
    Tomislav D. Zbozinek, Sahib S. Khalsa, Michelle G. Craske · 2026 · BMJ
  86. The potential effect of d-cycloserine on the development of anxiety during exposure sessions in patients with agoraphobia
    Lena Pyrkosch, Leopold Maria Lautenbacher, Jennifer Mumm, Jens Plag, Lydia Fehm, Thomas Fydrich, Andreas Ströhle · 2024 · Journal of Psychiatric Research
  87. Is a Combination of Pharmacotherapy and Psychotherapy Superior to Each Alone?
    Kwang‐Yeon Choi, Yong‐Ku Kim · 2017 · Springer eBooks
  88. Pilot Study of Self-Distancing Augmentation to Exposure Therapy for Youth Anxiety
    Emily L. Bilek, Allison E. Meyer, Rachel C. Tomlinson, Carol R Chen · 2023 · Child Psychiatry & Human Development
  89. Nichtansprechen auf Psychotherapie: Konzepte, Problemstellungen, Zuweisungsoptionen
    Jürgen Hoyer, Jens Plag · 2024 · Der Nervenarzt
  90. Anxiety Disorders
    Joseph K. Carpenter, Kristina Conroy, Stefan G. Hofmann · 2018 · Cambridge University Press eBooks
  91. Antidepressiva
    Francesca Regen, Otto Benkert · 2018 · Springer eBooks
  92. Treatment of anxiety disorders
    David S. Baldwin, Nathan T. M. Huneke · 2020
  93. Experimental psychopathology should not be examined with rose-tinted glasses
    Ioana A. Cristea · 2018 · The Lancet Psychiatry
  94. Fear-related anxiety disorders and posttraumatic stress disorder
    Moreland-Capuia, Alisha R., Vahabzadeh, Arshya, Gillespie, Charles F., Ressler, Kerry J. · 2023 · Neurobiology of Brain Disorders
  95. Clinical, genetic, and sociodemographic predictors of symptom severity after internet-delivered cognitive behavioural therapy for depression and anxiety
    Olly Kravchenko, Julia Bäckman, David Mataix‐Cols, James J. Crowley, Matthew Halvorsen, Patrick F. Sullivan, John Wallert, Christian Rück · 2025 · BMC Psychiatry
  96. Approved and Pipeline Pharmacological Interventions for Eating Disorders (2010–2025): 15 Years of Progress (or Lack Thereof)
    Drew Hirsch, Jace Reed, Aasim Naqvi, Ashley Ngor, Lauren Dugan, Kelly Costa, Rolando Sceptre Ganasi, Kyla A. Truman, Itai Danovitch, Waguih William IsHak et al. · 2025 · CNS Drugs
  97. Stress, Vulnerability, and Suicide
    Kees van Heeringen · 2018 · Cambridge University Press eBooks
  98. A randomized pharmacological fMRI trial investigating d-cycloserine and brain plasticity mechanisms in learned pain responses
    Mia Athina Thomaidou, Joseph S. Blythe, Dieuwke Swaantje Veldhuijzen, Kaya J. Peerdeman, Johan P. A. van Lennep, Erik J. Giltay, Henk R. Cremers, Andrea W.M. Evers · 2022 · Scientific Reports
  99. Augmentation of Psychotherapy with D-Cycloserine in Patients with Anxiety Disorders
    Leopold Maria Lautenbacher, Lena Pyrkosch, Lea Mascarell-Maricic, Andreas Ströhle · 2022 · Springer eBooks
  100. Combinaison de la kétamine et de l’eskétamine avec la thérapie d’exposition avec prévention de la réponse (EPR) dans le trouble obsessionnel-compulsif
    Hugo Bottemanne, Alice Arnould, Amaury Najar, Fanny Delaigue, Laure Serresse, Lucie Joly, Stéphane Mouchabac · 2023 · L Encéphale